Just goes to show how under the radar this is flying over there - I don't think we need anything much in the way of progress for a substantial re-rate, only to get on the list of options for OA treatment under trial. IND approval should get us on that sort of list.
research reports and media, page-1524
-
- There are more pages in this discussion • 2,832 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.010(4.08%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 26.0¢ | 24.5¢ | $64.94K | 253.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 70205 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 3003 | 2 |
View Market Depth
| Last trade - 15.53pm 01/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |